Mirum Pharmaceuticals vs Scholar Rock Holding
Mirum Pharmaceuticals (MIRM), health care, and Scholar Rock Holding (SRRK), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Mirum Pharmaceuticals is worth $6B on the stock market and Scholar Rock Holding $5.5B: Mirum Pharmaceuticals is valued at 9% more. Over the past year Mirum Pharmaceuticals's share price has moved +26.9% and Scholar Rock Holding's +11.9%.
Key facts
- Mirum Pharmaceuticals market value
- $6B
- Scholar Rock Holding market value
- $5.5B
- Mirum Pharmaceuticals revenue
- $521.3MFY to 2025-12-31
- Scholar Rock Holding revenue
- $0FY to 2025-12-31
- Superinvestors holding both
- 1
Market values as of .
| Measure | Mirum Pharmaceuticals | Scholar Rock Holding |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $6Bhigher | $5.5Blower |
| Revenue | $521.3Mhigher | $0lower |
| Earnings | -$23.4Mhigher | -$377.9Mlower |
| Employees | 470higher | 289lower |
| Total assets | $842.8Mhigher | $404.3Mlower |
| Valuation | ||
| P/E | — | — |
| P/S | 11.5 | — |
| P/B | — | 32.6 |
| Dividend yield | 0.00% | 0.00% |
| Profitability | ||
| Operating margin | -4.25% | — |
| Balance sheet | ||
| Net assets | $314.7Mhigher | $245.5Mlower |
| Total liabilities | $528.1Mhigher | $158.8Mlower |
| Total debt | — | $99.7M |
| Cash on hand | $296.7Mlower | $323.5Mhigher |
| Price change | ||
| Today | +0.40%lower | +1.21%higher |
| 1 year | +26.9%higher | +11.9%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (1)
- Polen Capital team<0.1% / <0.1%
Mirum Pharmaceuticals only (2)
Scholar Rock Holding only (2)
- Doug Silverman0.3%
- Brandon Haley0.2%
Percentages are each holding's share of that investor's reported portfolio (under "Both": Mirum Pharmaceuticals / Scholar Rock Holding). Who owns MIRM · Who owns SRRK
More on Mirum Pharmaceuticals
Further comparisons
Mirum Pharmaceuticals against its closest peers
Scholar Rock Holding against its closest peers
Learn
Questions and answers
Which is bigger, Mirum Pharmaceuticals or Scholar Rock Holding?
By market value, Mirum Pharmaceuticals is the larger: $6B against $5.5B for Scholar Rock Holding. By revenue in its latest fiscal year, Mirum Pharmaceuticals is the larger: $521.3M against $0 for Scholar Rock Holding.
Which has the higher dividend yield?
Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which superinvestors own both Mirum Pharmaceuticals and Scholar Rock Holding?
In their latest 13F filings, Polen Capital team holds both.
Cite this page
Funkfolio, “Mirum Pharmaceuticals vs Scholar Rock Holding”, data as of 18 November 2026. https://funkfolio.com/compare/mirm-vs-srrk
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.